A radically redesigned CT platform unveiled by GE Healthcare at the RSNA meeting produces images of soft tissue that rival those taken using MR, according to GE executives, who are framing the platform as a wholly new breed of CT scanner.
A radically redesigned CT platform unveiled by GE Healthcare at the RSNA meeting produces images of soft tissue that rival those taken using MR, according to GE executives, who are framing the platform as a wholly new breed of CT scanner.
A work-in-progress in both technology and name, GE's new HD (high definition) CT produces detail never before seen in CT. HD scans reveal soft tissue in the bowel, bladder, and prostate; liver vasculature and muscle stratification; brain aneurysms and even the fine mesh of stents implanted to stabilize aneurysms.
"The old way of CT was to produce the same image quality but with more slices," said Brian Duchinsky, general manager of global CT at GE Healthcare. "What we've done is to change the image clarity to see a whole new type of image."
The new platform uses a totally reengineered imaging chain. The x-ray tube is redesigned to shape the focal spot to suit the target: head, chest, abdomen, and legs. Enhanced data acquisition systems optimize information handling using advanced reconstruction software and hardware. A new detector material, of which 98% is composed of the gemstone garnet, responds 150 times faster to the light created by x-ray strikes on the detector and cuts afterglow to one-tenth the previous time, substantially reducing signal noise.
"This cuts out a lot of the artifacts found in traditional CT imaging," said Dominic P. Smith, general manager of molecular imaging, CT marketing, and advanced applications. "Beam hardening goes away."
The platform also features Volume Shuttle, which synchronizes the patient table and detector to widen the area of coverage, covering blood perfusion of the brain, heart and lungs, or liver. Moving the patient back and forth and gating the data acquisitions can dynamically capture a swath 25 cm wide.
GE has developed a suite of reconstruction techniques to cut dose. They are catalysts for the adoption of technology that GE executives describe as being as fundamentally different as multidetector CT.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.